JVMTX
Price
$29.31
Change
-$0.22 (-0.75%)
Updated
Aug 15 closing price
Net Assets
23.59B
PMVEX
Price
$25.90
Change
-$0.15 (-0.58%)
Updated
Aug 15 closing price
Net Assets
163.28M
Interact to see
Advertisement

JVMTX vs PMVEX

Header iconJVMTX vs PMVEX Comparison
Open Charts JVMTX vs PMVEXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$29.31
Change-$0.22 (-0.75%)
VolumeN/A
Net Assets23.59B
PGIM Quant Solutions Mid-Cap Val R2
Price$25.90
Change-$0.15 (-0.58%)
VolumeN/A
Net Assets163.28M
JVMTX vs PMVEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVMTX vs. PMVEX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and PMVEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.6B vs. PMVEX (163M). PMVEX pays higher dividends than JVMTX: PMVEX (1.29) vs JVMTX (0.64). JVMTX was incepted earlier than PMVEX: JVMTX (12 years) vs PMVEX (8 years). PMVEX (25.08) is less costly to investors than JVMTX (1.11). PMVEX is a more actively managed with annual turnover of: 97.00 vs. JVMTX (49.00). JVMTX (0) and PMVEX (0) have matching initial minimum investment requirements. PMVEX annual gain was more profitable for investors over the last year : 8.41 vs. JVMTX (0.62). PMVEX return over 5 years is better than : 88.85 vs. JVMTX (49.36).
JVMTXPMVEXJVMTX / PMVEX
Total Expense Ratio1.001.2381%
Annual Report Gross Expense Ratio1.1125.084%
Fund Existence12 years8 years-
Gain YTD8.9195.327167%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets23.6B163M14,479%
Annual Yield % from dividends0.641.2950%
Returns for 1 year0.628.417%
Returns for 3 years11.5817.7765%
Returns for 5 years49.3688.8556%
Returns for 10 years43.95N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHSX37.130.56
+1.53%
Hartford Healthcare R4
FCGYX20.340.03
+0.15%
NYLI PineStone Global Equity Class C
SUVAX12.58-0.05
-0.40%
PGIM Quant Solutions Large-Cap Val A
LCGRX24.80-0.10
-0.40%
Loomis Sayles Small Cap Growth Retail
PRVIX53.38-0.23
-0.43%
T. Rowe Price Small-Cap Value I